DL
Dane Leone Raymond James Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Relay Therapeutics
RLAY
$710M
| $4.12 | $19 |
361%
upside
| Strong Buy | 29 days ago |
|
2
Regenxbio
RGNX
$490M
| $9.71 | $45 |
363%
upside
| Outperform | 1 year ago |
|
3
Revolution Medicines
RVMD
$7.57B
| $40.50 | $30 |
26%
downside
| Outperform | 1 year ago |
|
4
Regeneron Pharmaceuticals
REGN
$60.8B
| $573.38 | $950 |
66%
upside
| Outperform | 1 year ago |
|
5
BridgeBio Pharma
BBIO
$10.2B
| $53.38 | $46 |
14%
downside
| Outperform | 2 years ago |
|
6
Galapagos
GLPG
$2.2B
| $33.36 | $69 |
107%
upside
| Outperform | 2 years ago |
|
7
Compass Therapeutics
CMPX
$590M
| $3.44 | $8 |
133%
upside
| Outperform | 2 years ago |
|
8
Ocular Therapeutix
OCUL
$2.37B
| $13.60 | $14 |
3%
upside
| Strong Buy | 2 years ago |
|
9
Xencor
XNCR
$610M
| $8.55 | $58 |
578%
upside
| Strong Buy | 2 years ago |
|
10
Simulations Plus
SLP
$279M
| $13.84 | $70 |
406%
upside
| Outperform | 3 years ago |
|
11
Cytokinetics
CYTK
$6.34B
| $53.01 | $63 |
19%
upside
| Outperform | 3 years ago |
|
12
Tarsus Pharmaceuticals
TARS
$2.43B
| $57.63 | $65 |
13%
upside
| Strong Buy | 3 years ago |
|
13
Amgen
AMGN
$153B
| $283.64 | $255 |
10%
downside
| Outperform | 4 years ago |
|